Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,079 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01093586

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +141 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

NCT01634217

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +38 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma

NCT01549431

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

Emory University Winship Cancer Institute Atlanta, Georgia, United States

University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission

NCT01349569

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

NCT02240719

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +35 more
Locations: University of California Davis Sacramento, California, United States

View Trial Details

Completed

Carfilzomib, Rituximab and Dexamethasone in Waldenstrom's Macroglobulinemia

NCT01470196

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

NCT00295932

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations: Winship Cancer Institute of Emory University Atlanta, Georgia, United States

Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States

Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States

View Trial Details

Completed

Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

NCT00003245

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +36 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT

NCT00709592

Conditions: Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +36 more
Locations: Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

NCT01499147

Conditions: Acute Leukemia, Acute Myeloid Leukemia, Anemia, +51 more
Locations: University of Illinois at Chicago Medical Center Chicago, Illinois, United States

View Trial Details

Hemostatic Disorders

Hemostatic Disorders trial results

Related conditions